HUNGARY: Chlamydia Prevalence and Correlates Among Female Adolescents in Hungary CDC Daily UpdateImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




HUNGARY: Chlamydia Prevalence and Correlates Among Female Adolescents in Hungary

Journal of Adolescent Health Vol. 41; No. 5: P. 513-515 (11..07) - Monday, December 17, 2007
Andras Ujhazy, MD; Akos Csaba, MD; Szabolcs Mate, MD; Zoltan Papp, MD, DSc; Istvan Sziller, MD, PhD


The authors' object in the current study was to evaluate the prevalence and the behavioral determinants of genital chlamydia infection among adolescent females in Hungary.

Questionnaires were given to 214 consecutive, unselected, self-referred, sexually active, non-pregnant females ages 16- 20. Polymerase chain reaction was used to detect chlamydia infection.

In this population, chlamydia prevalence was 7.9 percent. The most important correlates of chlamydia infection were at least three lifetime sexual partners (p<.005), two or more sexual partners in the preceding three months (p<.05), and symptoms of vaginitis (p=.002).

"The high prevalence of chlamydia in this study population may justify universal testing in Hungary," the authors concluded.
071217
AD072626


Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.